These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3979271

  • 1. [Serologic analysis of HBc antigen in patients with HBs-antigen carrier state].
    Möller B, Hopf U, Shirpai M, Lobeck H.
    Dtsch Med Wochenschr; 1985 Mar 15; 110(11):407-11. PubMed ID: 3979271
    [Abstract] [Full Text] [Related]

  • 2. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
    Alberti A, Diana S, Scullard GH, Eddleston WF, Williams R.
    Gastroenterology; 1978 Nov 15; 75(5):869-74. PubMed ID: 700329
    [Abstract] [Full Text] [Related]

  • 3. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B, Stalder GA, Gudat F, Bianchi L, Froesner GG.
    Schweiz Med Wochenschr; 1982 Apr 12; 112(15):523-4. PubMed ID: 7079688
    [Abstract] [Full Text] [Related]

  • 4. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR.
    Boll Ist Sieroter Milan; 1977 Mar 31; 56(1):74-8. PubMed ID: 861075
    [Abstract] [Full Text] [Related]

  • 5. [Classification and infectiousness of chronic hepatitis B, defined by the Dane particle in the blood and virus components in the liver].
    Gudat F, Bianchi L, Stalder GA, Schmid M.
    Schweiz Med Wochenschr; 1976 Jun 12; 106(24):812-24. PubMed ID: 792997
    [Abstract] [Full Text] [Related]

  • 6. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI.
    Rev Esp Enferm Dig; 1996 May 12; 88(5):335-9. PubMed ID: 8764540
    [Abstract] [Full Text] [Related]

  • 7. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V, Valesini G, Levrero M, Zaccari C, Van Dyke A, Falco M, Musca A, Balsano F.
    Clin Exp Immunol; 1985 May 12; 60(2):259-66. PubMed ID: 3874020
    [Abstract] [Full Text] [Related]

  • 8. Anti-HBc titers in HBeAg and anti-HBe positive asymptomatic HBsAg carriers.
    Hess G, Wagner J, Arnold W, Purcell RH, Meyer zum Büschenfelde KH.
    Z Immunitatsforsch Immunobiol; 1978 Jun 12; 154(3):208-17. PubMed ID: 676425
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers.
    Lazizi Y, Dubreuil P, Pillot J.
    Hepatology; 1993 Jun 12; 17(6):966-70. PubMed ID: 8514269
    [Abstract] [Full Text] [Related]

  • 11. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
    Tassopoulos NC, Papaevangelou GJ, Roumeliotou-Karayiannis A, Sjogren MH, Engle R, Karpodini E, Purcell RH.
    Hepatogastroenterology; 1986 Aug 12; 33(4):151-4. PubMed ID: 3758906
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R, Dentico P, Santantonio T, Frappampina V, Spinelli A, Amato M, Pastore G.
    Boll Soc Ital Biol Sper; 1980 Oct 30; 56(20):2076-82. PubMed ID: 7459119
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
    Perrillo RP, Gelb L, Campbell C, Wellinghoff W, Ellis FR, Overby L, Aach RD.
    Gastroenterology; 1979 Jun 30; 76(6):1319-25. PubMed ID: 437428
    [Abstract] [Full Text] [Related]

  • 16. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP, Chau KH, Overby LR, Decker RH.
    Gastroenterology; 1983 Jul 30; 85(1):163-7. PubMed ID: 6406288
    [Abstract] [Full Text] [Related]

  • 17. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
    Arnold W, Hess G, Dormeyer HH, Gahl G, Hoffmann HG, Knolle J, Schönborn H.
    Z Gastroenterol; 1979 Oct 30; 17(10):704-12. PubMed ID: 118595
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
    Zoulim F, Capel F, Berthillon P, Trépo C, Petit MA.
    Gastroenterol Clin Biol; 1995 Dec 30; 19(12):970-5. PubMed ID: 8729407
    [Abstract] [Full Text] [Related]

  • 19. [Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis].
    Dentico P, Pastore G, Buongiorno R, Angarano G, Lapedota E, Schiraldi O.
    Boll Soc Ital Biol Sper; 1979 Jul 15; 55(12):1141-6. PubMed ID: 317942
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B core antigen and antibody.
    Hoofnagle JH, Gerety RJ, Barker LF.
    Dev Biol Stand; 1975 Jul 15; 30():175-85. PubMed ID: 1204955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.